BLBaptiste Legrand

Baptiste Legrand

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Baptiste Legrand has a total of 268 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Water-soluble and self-assembling DAN & NDI based peptide aromatic oligomers

    by François Salbert, Luc Brunel, Baptiste Legrand, Gilles Subra, Muriel Amblard, Anthony R. Martin

    New DAN and NDI modified α-amino acids and their use for the CT-driven intermolecular association of peptide derivatives in water.

  • A Looplike Secondary Structure Uncovered in a Family of Peptoid Hexamers

    by Zacharie Bordas, Baptiste Legrand, Souleymane Sarr, Anne-Sophie Biesse-Martin, Emmanuel Wenger, Claude Didierjean, Olivier Roy, Sophie Faure, Claude Taillefumier

    Peptoids, or N-substituted glycine oligomers, are a unique class of biomimetic foldamers. Peptoid oligomers are indeed capable of adopting well-defined ordered structures despite their intrinsic flexibility, which is primarily attributable to the cis/trans isomerism of the main chain tertiary amide bonds. Controlling the geometry of the amides can lead to a diversity of diastereomeric structures. Here, we report for the first time that peptoid hexamers can adopt a unique looplike structure with a cis–cis–trans–cis–cis arrangement of the backbone amides. We found that a neutral zwitterionic state is necessary for the formation and stabilization of this structure by ion–pair interaction between the positively and negatively charged N- and C-termini. The novel loop structure exhibits a remarkable stability in chloroform and acetonitrile. In methanol, the oligomers adopt the more common polyproline type I (PPI) helical conformation. A comprehensive NMR solution structure determination was carried out on a hexamer containing four central (S)–N-(1-phenylethyl)glycines (Nspe) and two N-tert-butylglycines at the terminal ends. Our study reveals a distinct circular dichroism (CD) fingerprint for loop-shaped peptoids containing chiral aromatic Nspe monomers. The structure in solution was corroborated by a high-resolution crystal structure. Furthermore, we provide evidence that substituting the aromatic Nspe units with aliphatic (S)–N-(1-cyclohexylethyl)glycines (Nsch) or (S)–N-(1-tert-butylethyl)glycines (Nstbe) monomers does not impact loop folding processes. Finally, we demonstrate a reversible conformational switch between the loop structure and the PPI helix in response to external acid–base stimuli. This reversible stimulus-driven structural reorganization opens up opportunities to develop on/off switchable systems for next-generation smart applications.

  • Open Access

    Azole γ‐Peptides Helix Switching via Heterocycle Substitutions

    by Samantha Chaise, Claude Didierjean, Audrey Gacogne, Maxime Fillaudeau, Young Kee Kang, Aurélien Lebrun, Jean‐Louis Bantignies, Dominique Housset, Muriel Amblard, Ludovic T. Maillard, et al.

    Precise control of peptide backbone folding through non‐covalent interactions remains a major challenge in foldamer design. In this work, we demonstrate that heteroatom substitutions program conformational switching in azole γ‐peptides by tuning intrinsic stereoelectronic effects within heterocyclic γ‐amino acids. Conformationally constrained thiazole‐ and oxazole‐based γ‐amino acids were designed to adopt conformations driven by either a C 9 or a C 7 intramolecular H‐bond depending on key 1,4‐X···O interactions (X = S or N). We previously showed that thiazole‐based oligomers form a well‐characterized canonical 9‐Helix. Here, permutation of the sulfur and nitrogen atoms within the heterocycle induces a stretched helical structure with alternating C 7 ‐turns and residues in extended conformations. This unusual topology arises from competition between seven‐membered intra‐residue H‐bonds and attractive S···N electrostatic‐chalcogen interactions. Reversing this effect through an S→O substitution affords oxazole‐derived oligomers that adopt a stable 7‐Helix stabilized by a continuous seven‐membered H‐bond network in solution. These findings show that simple heteroatom permutation or substitution allows control over heterocyclic γ‐peptide folding, thereby expanding opportunities for foldamer design in molecular recognition, catalysis, and biomedical applications.

  • Open Access

    Azole γ‐Peptides Helix Switching via Heterocycle Substitutions

    by Samantha Chaise, Claude Didierjean, Audrey Gacogne, Maxime Fillaudeau, Young Kee Kang, Aurélien Lebrun, Jean‐Louis Bantignies, Dominique Housset, Muriel Amblard, Ludovic T. Maillard, et al.

    Precise control of peptide backbone folding through non‐covalent interactions remains a major challenge in foldamer design. In this work, we demonstrate that heteroatom substitutions program conformational switching in azole γ‐peptides by tuning intrinsic stereoelectronic effects within heterocyclic γ‐amino acids. Conformationally constrained thiazole‐ and oxazole‐based γ‐amino acids were designed to adopt conformations driven by either a C 9 or a C 7 intramolecular H‐bond depending on key 1,4‐X···O interactions (X = S or N). We previously showed that thiazole‐based oligomers form a well‐characterized canonical 9‐Helix. Here, permutation of the sulfur and nitrogen atoms within the heterocycle induces a stretched helical structure with alternating C 7 ‐turns and residues in extended conformations. This unusual topology arises from competition between seven‐membered intra‐residue H‐bonds and attractive S···N electrostatic‐chalcogen interactions. Reversing this effect through an S→O substitution affords oxazole‐derived oligomers that adopt a stable 7‐Helix stabilized by a continuous seven‐membered H‐bond network in solution. These findings show that simple heteroatom permutation or substitution allows control over heterocyclic γ‐peptide folding, thereby expanding opportunities for foldamer design in molecular recognition, catalysis, and biomedical applications.

  • Open Access

    Role of Chirality in the Self-Assembly of Peptide-Polymer Architectures via PISA

    by Belkacem Tarek Benkhaled, Chaimaa Gomri, Lubomir Vezenkov, Baptiste Legrand, Maximilien Coronas, Gilles Subra, Vincent Ladmiral, Mona Semsarilar

    The present study investigates the impact of a chiral peptide-monomer on the process of self-assembly and its effect on the morphology of the prepared nanostructures. The methodology employed in this study is reversible addition fragmentation chain-transfer (RAFT) Polymerization-Induced Self-Assembly (PISA) of diblock copolymers containing self-assembling peptides (SAP). The polymerizable peptide used is a methacrylamide-functionalized Gly-Phe-Phe sequence (GFF) with four different stereoisomers(GFDFD, GFDFL, GFLFL, and GFLFD). By incorporating these GFF tripeptides into the stabilising macro-chain transfer agent and extending the chain with a hydrophobic monomer under PISA conditions, diblock copolymer nano-objects of poly((Gly-Phe-Phe-methacrylamide)-co-glycerol monomethacrylate)-b-poly(2-hydroxypropylmethacrylate) (P(GFF-GMA)-b-HPMA) were prepared. The incorporation of the GFF stereoisomers has a direct influence on the self-assembled morphologies as demonstrated by various characterization methods.

  • Stereoelectronic Tuning of Heteroaromatic γ-Amino Acids for Turn Mimetic Design

    by Samantha Chaise, Audrey Gacogne, Ilan Garcin, Dominique Granier, Arie Van der Lee, Renata Marcia de Figueiredo, Jean-Marc Campagne, Young Kee Kang, Jean-Louis Bantignies, Baptiste Legrand, et al.

    In this work, we developed two novel heterocyclic γ-amino acids (Het-γAAs) based on thiazole and oxazole rings, preorganized in a C7-turn reminiscent of the peptide γ-turn in solution. Due to their role in stereoelectronic effects, the heteroatoms in the heterocycle act as a molecular switch, allowing control over conformations and stabilities of peptide turns.


  • Open Access

    Extreme thrombocytosis with an aggressive evolution harboring a novel variant of calreticulin (CALR) in exon 3

    by Sarah Bonnet, Serge Carillo, Baptiste Legrand, Barbara Burroni, Thierry Lavabre‐Bertrand, Guilhem Requirand, Nicolas Robert, Lea Fornero, Ahmed Al Mansoori, Jérôme Moreaux, et al.

    We describe the case of a patient with extreme thrombocytosis whose evolution was rapidly fatal. No cause of secondary thrombocytosis was found. There was no sign of myelofibrosis but the megakaryocytes were small and dysplastic. The patient presented a calreticulin (CALR) variant in exon 3 (C105S), as well as concomitant mutations of ASXL1, U2AF1, and EZH2. This variant of CALR has never been described before, and after sorting, all identified mutations were found in myeloid cells but not in lymphoid cells. Therefore, the diagnosis of a frontier case of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) was made. A treatment with hydroxycarbamide was started because of a high risk of thrombosis. Upon worsening of the hematological status two new mutations appeared, SETBP1 and ETV6, and the CALR mutation was still detectable, as well as the three other mutations found in the chronic stage. Our results show that this variant could contribute to MDS/MPN pathogenesis in that patient.


  • Planar Chiral p,p′-Terphenyl-Based Cyclophanes with Remarkable Enantiomer Stability: Synthesis, Theoretical Investigations, and Complexation Studies

    by Ioan Stroia, Mădălina Elena Moisă, Alexandra Pop, Baptiste Legrand, Anamaria Hanganu, Niculina Daniela Hădade, Ion Grosu

    Design of conformationally stable compounds with planar chirality is a topic of great interest mainly because of their potential applications as enantioselective ligands or other functional materials. Herein, we present the design and synthesis of novel planar chiral cyclophanes, obtained by ortho, ortho″ anchoring of the p,p'-terphenyl unit, with bridges of different lengths and rigidities, along with their nuclear magnetic resonance, mass spectrometry, and X-ray characterizations. We investigated the influence of the structural particularities of the bridges over the stability of the enantiomers, by means of nuclear magnetic resonance and chiral high-performance liquid chromatography as well as by density functional theory calculations. We also demonstrated the ability of one of the cyclophanes to preferentially bind arginine with Ka > 110 M-1 (ΔG > -11 kJ mol-1) in acetonitrile solutions containig 10 % water, in the presence of other amino acids.


  • Mapping the N-Terminal Hexokinase-I Binding Site onto Voltage-Dependent Anion Channel-1 To Block Peripheral Nerve Demyelination

    by Benoit Gautier, Mélanie Forêt Jacquard, Sophie Guelfi, Scarlette Abbou, Elisa Gonzalez, Jade Berthelot, Hassan Boukhaddaoui, Aurélien Lebrun, Baptiste Legrand, Nicolas Tricaud, et al.

    The voltage-dependent anion channel (VDAC), the most abundant protein on the outer mitochondrial membrane, is implicated in ATP, ion and metabolite exchange with cell compartments. In particular, the VDAC participates in cytoplasmic and mitochondrial Ca2+ homeostasis. Notably, the Ca2+ efflux out of Schwann cell mitochondria is involved in peripheral nerve demyelination that underlies most peripheral neuropathies. Hexokinase (HK) isoforms I and II, the main ligands of the VDAC, possess a hydrophobic N-terminal structured in alpha-helix (NHKI) that is necessary for the binding to the VDAC. To gain further insight into the molecular basis of HK binding to the VDAC, we developed and optimized peptides based on the NHKI sequence. These modifications lead to an increase of the peptide hydrophobicity and helical content that enhanced their ability to prevent peripheral nerve demyelination. Our results provide new insights into the molecular basis of VDAC/HK interaction that could lead to the development of therapeutic compounds for demyelinating peripheral neuropathies.


  • Potent Lys Patch-Containing Stapled Peptides Targeting PCSK9

    by Kévin Bourbiaux, Baptiste Legrand, Pascal Verdié, Sergio Mallart, Géraldine Manette, Claire Minoletti, J. David Stepp, Philippe Prigent, Jean-Christophe Le Bail, Laurence Gauzy-Lazo, et al.

    Proprotein convertase subtilisin/kexin type 9 (PCSK9), identified as a regulator of low-density lipoprotein receptor (LDLR), plays a major role in cardiovascular diseases (CVD). Recently, Pep2-8, a small peptide with discrete three-dimensional structure, was found to inhibit the PCSK9/LDLR interaction. In this paper, we describe the modification of this peptide using stapled peptide and SIP technologies. Their combination yielded potent compounds such as 18 that potently inhibited the binding of PCSK9 to LDLR (KD = 6 ± 1 nM) and restored in vitro LDL uptake by HepG2 cells in the presence of PCSK9 (EC50 = 175 ± 40 nM). The three-dimensional structures of key peptides were extensively studied by circular dichroism and nuclear magnetic resonance, and molecular dynamics simulations allowed us to compare their binding mode to tentatively rationalize structure–activity relationships (SAR).